A study published in Nature Medicine used data from 2.4 million participants to create an atlas of the benefits and risks of GLP-1 drugs in comparison to other commonly used antihyperglycemic drugs like sulfonylureas, dipeptidyl peptidase 4 (DPP4), and sodium-glucose cotransporter-2 (SGLT2) inhibitors
They may recommend: Liver function tests based on clinical judgement and your overall risk profile Strategies to minimise gastrointestinal side effects Referral to diabetes specialist nurses for education on hypoglycaemia prevention Signposting to alcohol support services if appropriate When to contact your GP urgently : Seek medical advice promptly if you experience severe abdominal pain (stop your GLP-1 medication if pancreatitis is suspected), persistent vomiting preventing medication or fluid intake, signs of dehydration, or symptoms of hypoglycaemia that don't resolve with usual measures
Jiang, Y
Branded Options When discussing Zepbound, it is important to understand the landscape of available treatments
We have seen that many individuals who improve their EF naturally who adopt significant lifestyle changes and proven therapies
Functional studies in rat models have demonstrated that injection of GLP-1 has a dose-dependent effect on reducing feeding behaviors [54, 55], providing evidence of its function as a satiety mediator